uniQure secures $175 million non-dilutive funding, extends debt term
PositiveFinancial Markets

uniQure has successfully secured $175 million in non-dilutive funding, which is a significant boost for the biotech company. This funding allows uniQure to extend its debt term, providing them with more financial flexibility to advance their innovative therapies. This development is crucial as it not only strengthens their financial position but also enhances their ability to invest in research and development, ultimately benefiting patients in need of cutting-edge treatments.
— Curated by the World Pulse Now AI Editorial System